Worse Clinical Outcomes in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Relevance to Impaired Endothelial Progenitor Cells Mobilization-Reference-Cited by-同舟云学术

Worse Clinical Outcomes in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Relevance to Impaired Endothelial Progenitor Cells Mobilization

Published:2012-11-30 Issue:11 Volume:7 Page:e50739
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ling Lin,Shen Yu,Wang Kun,Jiang Chunying,Fang Chunmei,Ferro Albert,Kang Lina,Xu Biao

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus;SP Marso;Am J Cardiol,2007

2. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction;KJ Harjai;Am J Cardiol,2003

3. Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention;NL Mills;Heart,2009

4. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair;C Schmidt-Lucke;Circulation,2005

5. Circulating endothelial progenitor cells and cardiovascular outcomes;N Werner;N Engl J Med,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes;Cardiovascular Research;2024-07-19

2. Bone marrow vasculature advanced in vitro models for cancer and cardiovascular research;Frontiers in Cardiovascular Medicine;2023-10-17

3. Prognostic Value of Endothelial Progenitor Cells in Acute Myocardial Infarction Patients;Mediators of Inflammation;2023-09-28

4. Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes;Stem Cells;2022-05-12

5. Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes;Antioxidants & Redox Signaling;2022-01-04